Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1978 1
1991 3
1993 1
1997 1
1998 2
1999 1
2000 3
2001 1
2003 7
2007 1
2008 1
2009 4
2010 5
2011 1
2012 1
2013 3
2015 2
2016 3
2017 3
2018 3
2019 6
2020 3
2021 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Lead Exposure and Oxidative Stress: A Systematic Review.
Lopes AC, Peixe TS, Mesas AE, Paoliello MM. Lopes AC, et al. Rev Environ Contam Toxicol. 2016;236:193-238. doi: 10.1007/978-3-319-20013-2_3. Rev Environ Contam Toxicol. 2016. PMID: 26423075 Review.
Lead is an environmental toxicant that can induce oxidative stress (OS) via reactive oxygen species (ROS) generation, which has been reported as an important mechanism underlying lead toxicity (Gurer and Ercal 2000; Pande and Flora 2002; Kasperczyk et al. 2004a; Farmand et al. 20 …
Lead is an environmental toxicant that can induce oxidative stress (OS) via reactive oxygen species (ROS) generation, which has been reporte …
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
METHODS: In a randomized, double-blind, noninferiority study, we randomly assigned patients with acute venous thromboembolism, who had initially received heparin, to receive edoxaban at a dose of 60 mg once daily, or 30 mg once daily (e.g., in the case of patients with cre …
METHODS: In a randomized, double-blind, noninferiority study, we randomly assigned patients with acute venous thromboembolism, who had initi …
COVID-19 Neurological Manifestations and Underlying Mechanisms: A Scoping Review.
Wenting A, Gruters A, van Os Y, Verstraeten S, Valentijn S, Ponds R, de Vugt M. Wenting A, et al. Front Psychiatry. 2020 Aug 21;11:860. doi: 10.3389/fpsyt.2020.00860. eCollection 2020. Front Psychiatry. 2020. PMID: 32973590 Free PMC article. Review.
CONCLUSION: Neurological manifestations of COVID-19 vary from mild (e.g. loss of taste and smell, dizziness, headache) to severe (e.g. ischemic stroke, encephalitis). ...
CONCLUSION: Neurological manifestations of COVID-19 vary from mild (e.g. loss of taste and smell, dizziness, headache) to severe (e. …
Biochemical determinants of ObgE-mediated persistence.
Verstraeten N, Gkekas S, Kint CI, Deckers B, Van den Bergh B, Herpels P, Louwagie E, Knapen W, Wilmaerts D, Dewachter L, Fauvart M, Singh RK, Michiels J, Versées W. Verstraeten N, et al. Mol Microbiol. 2019 Nov;112(5):1593-1608. doi: 10.1111/mmi.14382. Epub 2019 Sep 18. Mol Microbiol. 2019. PMID: 31498933 Free article.
We previously showed that the Escherichia coli homolog ObgE exerts this activity through transcriptional activation of a toxin-antitoxin module and subsequent membrane depolarization. Here, we assessed the role of G-domain functionality in ObgE-mediated persistence. Throug …
We previously showed that the Escherichia coli homolog ObgE exerts this activity through transcriptional activation of a toxin-antitoxin mod …
Basic biochemical mechanisms behind the health benefits of polyphenols.
Fraga CG, Galleano M, Verstraeten SV, Oteiza PI. Fraga CG, et al. Mol Aspects Med. 2010 Dec;31(6):435-45. doi: 10.1016/j.mam.2010.09.006. Epub 2010 Sep 18. Mol Aspects Med. 2010. PMID: 20854840 Review.
Those mechanisms include: i) non specific actions, based on chemical features common to most polyphenols, e.g. the presence of a phenol group to scavenge free radicals; and ii) specific mechanisms; based on particular structural and conformational characteristics of select …
Those mechanisms include: i) non specific actions, based on chemical features common to most polyphenols, e.g. the presence of a phen …
Antioxidant actions of flavonoids: thermodynamic and kinetic analysis.
Galleano M, Verstraeten SV, Oteiza PI, Fraga CG. Galleano M, et al. Arch Biochem Biophys. 2010 Sep 1;501(1):23-30. doi: 10.1016/j.abb.2010.04.005. Epub 2010 Apr 11. Arch Biochem Biophys. 2010. PMID: 20388486 Review.
This incompatibility becomes evident when compared to other antioxidant compounds, e.g. alpha-tocopherol (vitamin E), ascorbate (vitamin C), and glutathione. ...
This incompatibility becomes evident when compared to other antioxidant compounds, e.g. alpha-tocopherol (vitamin E), ascorbate (vita …
Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).
Zepp F, Schmitt HJ, Cleerbout J, Verstraeten T, Schuerman L, Jacquet JM. Zepp F, et al. Expert Rev Vaccines. 2009 Jun;8(6):663-78. doi: 10.1586/erv.09.32. Expert Rev Vaccines. 2009. PMID: 19485747 Review.
These data show DTPa-HBV-IPV/Hib to be highly immunogenic and well tolerated across a range of different primary and booster vaccination schedules, as well as when administered concomitantly with other licensed vaccines (e.g., pneumococcal conjugate vaccine). Additional is …
These data show DTPa-HBV-IPV/Hib to be highly immunogenic and well tolerated across a range of different primary and booster vaccination sch …
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. PLoS One. 2023 Mar 30;18(3):e0283643. doi: 10.1371/journal.pone.0283643. eCollection 2023. PLoS One. 2023. PMID: 36996258 Free PMC article.
59 results